Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain shams University, Cairo, Egypt.
Pharmacology Department, National Research Centre (NRC), Cairo, Egypt.
Drug Dev Ind Pharm. 2024 May;50(5):460-469. doi: 10.1080/03639045.2024.2341786. Epub 2024 Apr 13.
Ferulic acid (FA) is a promising nutraceutical molecule which exhibits antioxidant and anti-inflammatory properties, but it suffers from poor solubility and bioavailability. In the presented study, FA nanoemulsions were prepared to potentiate the therapeutic efficacy of FA in prevention of gastric ulcer.
FA nanoemulsions were prepared, pharmaceutically characterized, and the selected nanoemusion was tested for its ulcer-ameliorative properties in rats after induction of gastric ulcer using ethanol, by examination of stomach tissues, assessment of serum IL-1β and TNF-α, assessment of nitric oxide, prostaglandin E2, glutathione, catalase and thiobarbituric acid reactive substance in stomach homogenates, as well as histological and immunohistochemical evaluation.
Results revealed that the selected FA nanoemulsion showed a particle size of 90.43 nm, sustained release of FA for 8 h, and better anti-inflammatory properties than FA. Moreover, FA nanoemulsion exhibited significantly better anti-inflammatory and antioxidant properties , and the gastric tissue treated with FA nanoemulsion was comparable to the normal control upon histological and immunohistochemical evaluation.
Findings suggest that the prepared ferulic acid nanoemulsion is an ideal anti-ulcer system, which is worthy of further investigations.
阿魏酸(FA)是一种很有前途的营养药物分子,具有抗氧化和抗炎特性,但它的溶解度和生物利用度较差。在本研究中,制备了 FA 纳米乳剂,以增强 FA 在预防胃溃疡中的治疗效果。
制备 FA 纳米乳剂,进行药物特性分析,并在使用乙醇诱导大鼠胃溃疡后,用所选纳米乳剂对其溃疡缓解特性进行测试,通过检查胃组织、评估血清 IL-1β 和 TNF-α、评估一氧化氮、前列腺素 E2、谷胱甘肽、胃匀浆中的过氧化氢酶和硫代巴比妥酸反应物质,以及组织学和免疫组织化学评估。
结果表明,所选 FA 纳米乳剂的粒径为 90.43nm,FA 持续释放 8h,且具有比 FA 更好的抗炎特性。此外,FA 纳米乳剂表现出明显更好的抗炎和抗氧化特性,并且用 FA 纳米乳剂处理的胃组织在组织学和免疫组织化学评估中与正常对照组相当。
研究结果表明,所制备的阿魏酸纳米乳剂是一种理想的抗溃疡系统,值得进一步研究。